Mepur H. Ravindranath

Author

Also Known As

M H Ravindranath, M Ravindranath, M. H. RAVINDRANATH, M. H. Ravindranath, M. Ravindranath, M.H. Ravindranath, MEPUR H. RAVINDRANATH, MH Ravindranath2, Mepur H Ravindranath, Mepur H. RAVINDRANATH

151

Publications

2.9K

Citations

H-Index

123

Concepts

All Affiliations

Saint John's Health Center Terasaki Foundation University of Madras Hoag Memorial Hospital Presbyterian Pacific Clinical Research

About

Mepur H. Ravindranath is an author at Saint John's Health Center specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	40	1.4K
2	Natural Sciences	5	5	218
3	Health Sciences	4	4	82
4	Engineering	2	2	45
5	Public Health	1	1	88

Mepur H. Ravindranath

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Purification and characterization of an O-acetylsialic acid-specific lectin from a marine crab Cancer antennarius. Mepur H. Ravindranath, H H Higa, Edwin L. Cooper, Journal of Biological Chemistry BiologyO-acetylsialic Acid-specific LectinMarine BiotechnologyBiochemistryNatural Sciences	1985	162
Prolonged Survival of Patients Receiving Active Immunotherapy With Canvaxin Therapeutic Polyvalent Vaccine After Complete Resection of Melanoma Metastatic to Regional Lymph Nodes Donald L. Morton, Eddy C. Hsueh, Richard Essner, Annals of Surgery	2002	147
Ganglioside GM3:GD3 ratio as an index for the management of melanoma Mepur H. Ravindranath, Tetsuya Tsuchida, Donald L. Morton, Cancer Tumor BiologyGanglioside Gm3Stage Ii DiseaseMedicineGd3 Ratio	1991	93
Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender‐Dependent Human Cancer Cell Lines Mepur H. Ravindranath, Thiruverkadu S. Saravanan, Clarence C. Monteclaro, Evidence-based Complementary and Alternative Medicine Chemoprevention StrategyEpithelial Ovarian CancerTumor BiologyOvarian CancerCancer Cell Biology	2006	88
An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy. Mepur H. Ravindranath, D L Morton, Reiko F. Irie PubMed ImmunologyPathologyDermatologyImmunotherapyTumor Immunology	1989	66
Gangliosides of human melanoma: altered expression in vivo and in vitro. Tetsuya Tsuchida, Mepur H. Ravindranath, Romaine E. Saxton, PubMed Neuro-oncologyTumoral PathologyAltered ExpressionHuman MelanomaMedicine	1987	62
Differential Growth Suppression of Human Melanoma Cells by Tea (<i>Camellia sinensis</i>) Epicatechins (ECG, EGC and EGCG) Mepur H. Ravindranath, Vaishali Ramasamy, Songeun Moon, Evidence-based Complementary and Alternative Medicine Chemoprevention StrategyDermatologyTumor BiologyOxidative StressPhytopharmacology	2007	61
Antibodies to HLA-E in Nonalloimmunized Males: Pattern of HLA-Ia Reactivity of Anti–HLA-E–Positive Sera Mepur H. Ravindranath, Hugo Kaneku, Nadim El‐Awar, The Journal of Immunology HlaHistocompatibilityHla ImmunogeneticsImmunologyPathology	2010	59
Histochemical significance of green metachromasia to Toluidine blue Karthikeyan Ramalingam, Mepur H. Ravindranath Histochemie ColorimetryHistopathologyPathologyChemical PathologyToxicology	1970	56
Purification and characterization of <i>N</i>‐glycolylneuraminic‐acid‐specific lectin from <i>Scylla serrata</i> P. D. Sr. Mercy, Mepur H. Ravindranath European Journal of Biochemistry	1993	49

Page 1